Gerber Products Company

JANA Partners to Nominate Four Highly Qualified Directors to Freshpet Board

Retrieved on: 
Wednesday, May 24, 2023

JANA Partners (“JANA”) today announced that it will be nominating four highly qualified candidates to Freshpet, Inc.’s (“Freshpet” or the “Company”) (NASDAQ:FRPT) Board of Directors (the “Board”) for the 2023 Annual Meeting of Stockholders (“Annual Meeting”).

Key Points: 
  • JANA Partners (“JANA”) today announced that it will be nominating four highly qualified candidates to Freshpet, Inc.’s (“Freshpet” or the “Company”) (NASDAQ:FRPT) Board of Directors (the “Board”) for the 2023 Annual Meeting of Stockholders (“Annual Meeting”).
  • JANA’s nominees bring extensive experience as executives and public company board members in the consumer sector.
  • Diane Dietz, Former Chief Executive Officer of Rodan & Fields, EVP & Chief Marketing/Merchandising Officer of Safeway and EVP at Procter & Gamble.
  • JANA today issued the following public letter to Freshpet shareholders:
    JANA, along with our affiliates and partners, owns 9.3% of Freshpet, making us the Company’s largest shareholder.

World Dry Eye Syndrome Market Size, Share and Trends Analysis Report 2022-2027 - Increasing Research & Development and Promising Pipeline Products - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 8, 2023

The "Dry Eye Syndrome Market Size, Share and Trends Analysis by Region, Product, Therapy Area, Distribution Channel and Segment Forecast, 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Dry Eye Syndrome Market Size, Share and Trends Analysis by Region, Product, Therapy Area, Distribution Channel and Segment Forecast, 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The dry eye syndrome market report provides an executive-level overview of dry eye syndrome worldwide today, with detailed forecasts of key indicators up to 2027.
  • Overview of dry eye syndrome including industry trends, deals, and product & company profile
    dry eye syndrome market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the product, dosage form, distribution channel, and geographic segments
    Dry eye syndrome market outlook: analysis as well as forecasts of revenue opportunities from the key product segments
    Dry eye syndrome market outlook: analysis as well as forecasts of revenue opportunities from the dosage form segment.
  • Dry eye syndrome market outlook: analysis as well as forecasts of revenue opportunities from the distribution channel segment

Herborium® Group Inc, Shareholder Update Letter (Part 2)

Retrieved on: 
Wednesday, January 25, 2023

Following last week’s Shareholder Letter Part 1, this Part 2 is to present the major focus for 2023 and beyond.

Key Points: 
  • Following last week’s Shareholder Letter Part 1, this Part 2 is to present the major focus for 2023 and beyond.
  • This Plan stems from the analysis of lead market and scientific trends that are reshaping our space, and grounded in previously reported changes and advancements made in 2022.
  • This  creates value added to the customer and additional  revenues streams (paid counseling in skincare, beauty, nutrition etc.)
  • Furthermore,  we plan to continue our efforts to minimize debt, control dilution,  increase profitability and decrease cost.- all to further improve Corporate’ valuation and shareholder value.

Digital Health in Immunology Global Market Report 2022: Increasing Adoption of Digitization in Healthcare Bolsters 24.2% Annual Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, January 6, 2023

The digital health in immunology market size was valued at US$6.0 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 24.2% during 2022-2027.

Key Points: 
  • The digital health in immunology market size was valued at US$6.0 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 24.2% during 2022-2027.
  • The digital health in immunology market report provides an executive-level overview of the digital health in immunology market worldwide today, with detailed forecasts of key indicators up to 2027.
  • This market intelligence report offers a thorough, forward-looking analysis of the global digital health in immunology market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.
  • The digital health in immunology market size was valued at US$6.0 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 24.2% during the forecast period (2022-2027).

Atopic Dermatitis Global Market Report 2022: Lack of Therapeutic Options for Chronic Hand Eczema Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 20, 2022

The Global Atopic Dermatitis market report provides an executive-level overview of the atopic dermatits market worldwide today, with detailed forecasts of key indicators up to 2027.

Key Points: 
  • The Global Atopic Dermatitis market report provides an executive-level overview of the atopic dermatits market worldwide today, with detailed forecasts of key indicators up to 2027.
  • Atopic Dermatitis market outlook: analysis as well as forecasts of revenue opportunities from the drug class segments.
  • Atopic Dermatitis market outlook: analysis as well as forecasts of revenue opportunities from the route of administrtaion segment.
  • This market intelligence report offers a thorough, forward-looking analysis of the global Atopic Dermatitis market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.

Regenerative Medicine in Pharma Market to Grow by 11.1% Annually Through 2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, December 19, 2022

The Regenerative Medicine in Pharma market size was valued at US$29.4 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.1% during 2022-2027.

Key Points: 
  • The Regenerative Medicine in Pharma market size was valued at US$29.4 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.1% during 2022-2027.
  • The Regenerative Medicine in Pharma market report provides an executive-level overview of the regenerative medicine market worldwide today, with detailed forecasts of key indicators up to 2027.
  • Regenerative medicine in pharma market outlook: analysis as well as forecasts of revenue opportunities from the drug class segments.
  • Regenerative medicine in pharma market outlook: analysis as well as forecasts of revenue opportunities from the route of administration segment.

Diabetic Foot Ulcers Market Size, Share and Trends Analysis by Region, Treatment, Ulcers Type, End-user and Segment Forecast, 2022-2027

Retrieved on: 
Monday, December 19, 2022

The diabetic foot ulcers market report provides an executive-level overview of the diabetic foot ulcers market worldwide today, with detailed forecasts of key indicators up to 2027.

Key Points: 
  • The diabetic foot ulcers market report provides an executive-level overview of the diabetic foot ulcers market worldwide today, with detailed forecasts of key indicators up to 2027.
  • - Overview of the diabetic foot ulcers market including industry trends, pipeline analysis, regulatory details, and product & company profile
    - Diabetic foot ulcers market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the treatment, ulcers type, end-user, and geographic segments.
  • - Diabetic foot ulcers market outlook: analysis as well as forecasts of revenue opportunities from the ulcers type segment.
  • - Accompanying Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in diabetic foot ulcers market.

Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class, Route of Administration, and Segment Forecast, 2022-2027

Retrieved on: 
Friday, December 9, 2022

The Regenerative Medicine in Pharma market report provides an executive-level overview of the regenerative medicine market worldwide today, with detailed forecasts of key indicators up to 2027.

Key Points: 
  • The Regenerative Medicine in Pharma market report provides an executive-level overview of the regenerative medicine market worldwide today, with detailed forecasts of key indicators up to 2027.
  • - Overview of regenerative medicine in pharma market including industry trends, funding & deals, pipeline analysis, regulatory details, and product & company profile
    - Regenerative medicine in pharma market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the product, technology, application, and geographic segments.
  • - Regenerative medicine in pharma market outlook: analysis as well as forecasts of revenue opportunities from the drug class segments.
  • - Regenerative medicine in pharma market outlook: analysis as well as forecasts of revenue opportunities from the route of administration segment.

Gerber® and Entrepreneur and New Mom Nabela Noor Invite Parents to Celebrate Babies' First Tastes with a Chance to Win Free Baby Food for a Year

Retrieved on: 
Wednesday, September 28, 2022

ARLINGTON, Va., Sept. 28, 2022 /PRNewswire/ -- Today, early childhood nutrition leader Gerber is announcing a partnership with designer, author, entrepreneur, and new mom Nabela Noor to celebrate milestone first taste moments for babies across the country. To encourage fun and enjoyment during these exciting but sometimes messy moments, Nabela and Gerber have curated free, limited-edition First Bite Party Packs for a select number of fans. Gerber will also give away a year's supply of baby food to one randomly selected lucky winner.

Key Points: 
  • To encourage fun and enjoyment during these exciting but sometimes messy moments, Nabela and Gerber have curated free, limited-edition First Bite Party Packs for a select number of fans.
  • Gerber will also give away a year's supply of baby food to one randomly selected lucky winner.
  • To help parents ease into this moment, I worked with Gerber to curate a free, limited-edition First Bite Party Pack that celebrates babies' first bites and inspires parents to keep trying new tastes," Nabela Noor said.
  • "When our pediatrician let us know our 6-month-old, Amalia, was ready to begin exploring solid foods, we were so excited!

Gerber Announces New 1st Food® Puree Flavor Offerings in Natural Corn and Mango to Expand Flavor Profile and Increase Access to Variety of Exciting Flavors for Baby

Retrieved on: 
Wednesday, July 6, 2022

ARLINGTON, Va., July 6, 2022 /PRNewswire/ -- Early childhood nutrition leader Gerber is expanding its 1st Foods® puree line with the introduction of two new flavors– Gerber® Natural 1st Foods® Corn and Gerber® Natural 1st Foods® Mango. Developed to expand baby's dietary variety and introduce different nutrient-dense fruits and veggies to baby as they begin eating solid foods, the new Gerber corn and mango purees are both Non-GMO Project Verified, follow the Gerber Clean Field Farming practices and meet strict quality standards.

Key Points: 
  • ARLINGTON, Va., July 6, 2022 /PRNewswire/ -- Early childhood nutrition leader Gerber is expanding its 1stFoods puree line with the introduction of two new flavors Gerber Natural 1st Foods Corn and Gerber Natural 1st Foods Mango .
  • Gerber Natural 1st FoodsMango has 20% DV of potassium per serving, 2 servings of fruit per jar and contains no added sugar, artificial flavors, or colors.
  • Gerber's new flavors, Corn and Mango, provide babies opportunities to appreciate the diverse flavors of the world in a nutritious, approachable, and safe form.
  • Parents can purchase Gerber Natural 1st Foods Corn and Gerber Natural 1st Foods Mango at retailers nationwide including Walmart, Target, and Kroger.